The Lawyer’s new China Elite report contains the most detailed research available on the PRC legal market and contains unparalleled insight into the country's leading law firms. They vary in size, practice focus and geographic coverage, but they all share one common quality – ambition... Read more
An exhaustive analysis of the UK market including every firm in the top 200 ranked, analysed and benchmarked, UK chambers ranked by turnover, revenue per barrister and which international firms are most active in the UK.
Howrey has swooped on Taylor Wessing for the head of its life sciences practice Mark Hodgson in a move that signals the increasing depth of Howrey’s European IP team.
Hodgson, a partner at Taylor Wessing for nine years, is leaving because of the potential for conflicts between one of his key clients and his current firm’s wider IP practice.
Taylor Wessing head of IP Charles Lloyd said: “Mark’s decision to move follows a conflict of interest between a number of important clients that Taylor Wessing represents and an important client he’s advised for many years.
“Mark wishes to continue working with this client and we respect his career choice.”
The conflict concerns generic drug producers and original drug manufacturers represented by Hodgson, including Eli Lilly.
Hodgson joins Howrey on 30 April, when he will renew his acquaintance with former Simmons & Simmons colleague Richard Willoughby.
Willoughby said the hire showed how established Howrey had become within the London market. “We think we have one of the best pan-European IP teams now,” he said. “The sheer quality of the names speaks for itself.”